Desmoplakin cardiomyopathy: Myocardial injury, immune-mediated inflammatory diseases, and long-term clinical outcomes in a genotype-confirmed cohort
Polish Heart Journal · 20.11.2026
DOI: 10.33963/v.phj.115890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polish Heart Journal, online erschienen am 20.11.2026. Verfasst von Joanna Zakrzewska-Koperska und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Desmoplakin (DSP)-related cardiomyopathy is a distinct arrhythmogenic cardiomyopathy with predominant left ventricular involvement, myocardial fibrosis, and recurrent myocarditis-like episodes; data on long-term outcomes and disease modifiers are limited.
Aims
Our aim was to characterize clinical phenotype, myocardial injury, and long-term outcomes, focusing on sex-specific differences and immune-mediated inflammatory diseases (IMIDs).
Methods
Between 2012 and 2025, we identified 14 probands with likely pathogenic/pathogenic DSP variants by next-generation sequencing (10 from a previously characterized nationwide 280-proband dilated cardiomyopathy cohort, 4 subsequently) and 8 relatives via cascade screening, yielding 22 subjects analyzed for clinical, electrocardiographic, imaging, biomarker, and follow-up data.
Results
Median age at onset was 28 years (interquartile range [IQR] 18.7–40.3); 68% had non-dilated left ventricular cardiomyopathy and 86% had ventricular ectopy. Cardiac magnetic resonance (CMR) showed late gadolinium enhancement in 94% (15/16 with available CMR). High-sensitivity troponin T was elevated in 32%, with CMR inflammation in 37%. Over 145 months (IQR 61–150), heart failure (HF) progression occurred in 45%, sustained ventricular tachycardia in 31%, and biventricular involvement in 14%. IMIDs were identified in 23%, exclusively in women (46% vs. 0%; P = 0.019), who had more frequent HF progression (75% vs. 17%; P = 0.043). IMID-positive patients showed a trend toward earlier onset (19 vs. 31 years; P = 0.056); this was considered exploratory given confounding with female sex.
Conclusions
DSP-related cardiomyopathy is marked by extensive fibrosis, frequent ventricular arrhythmias, and progressive HF. IMIDs were observed exclusively in women, and female sex was associated with higher HF progression; this relationship remains exploratory and requires validation in larger cohorts.
Zitieren
APA
Zakrzewska-Koperska, J., Chmielewski, P., Truszkowska, G., Machaj, F., Jurek, M., Świerczewski, M., Śpiewak, M., Żebrowska, A. M., Rywik, T., Pelczar-Płachta, W., Bilińska, M., Szumowski, Ł., Płoski, R., & Bilińska, Z. T. (2026). Desmoplakin cardiomyopathy: Myocardial injury, immune-mediated inflammatory diseases, and long-term clinical outcomes in a genotype-confirmed cohort. Polish Heart Journal. https://doi.org/10.33963/v.phj.115890
Vancouver
Zakrzewska-Koperska J, Chmielewski P, Truszkowska G, Machaj F, Jurek M, Świerczewski M, et al. Desmoplakin cardiomyopathy: Myocardial injury, immune-mediated inflammatory diseases, and long-term clinical outcomes in a genotype-confirmed cohort. Polish Heart Journal. 2026. doi:10.33963/v.phj.115890
BibTeX
@article{ZakrzewskaKoperska2026,
author = {Zakrzewska-Koperska, Joanna and Chmielewski, Przemysław and Truszkowska, Grażyna and Machaj, Filip and Jurek, Marta and Świerczewski, Michał and Śpiewak, Mateusz and Żebrowska, Agnieszka M and Rywik, Tomasz and Pelczar-Płachta, Weronika and Bilińska, Maria and Szumowski, Łukasz and Płoski, Rafał and Bilińska, Zofia T},
title = {Desmoplakin cardiomyopathy: Myocardial injury, immune-mediated inflammatory diseases, and long-term clinical outcomes in a genotype-confirmed cohort},
journal = {Polish Heart Journal},
year = {2026},
doi = {10.33963/v.phj.115890}
}
EUVIMED